Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	DH_1	PLEKHG4B PLEKHG1 AKAP13 ARHGEF17	2.42e-04	63	90	4	PS00741
Domain	RhoGEF	PLEKHG4B PLEKHG1 AKAP13 ARHGEF17	3.24e-04	68	90	4	SM00325
Domain	RhoGEF	PLEKHG4B PLEKHG1 AKAP13 ARHGEF17	3.63e-04	70	90	4	PF00621
Domain	DH_2	PLEKHG4B PLEKHG1 AKAP13 ARHGEF17	3.63e-04	70	90	4	PS50010
Domain	DH-domain	PLEKHG4B PLEKHG1 AKAP13 ARHGEF17	3.83e-04	71	90	4	IPR000219
Domain	-	PLEKHG4B PLEKHG1 AKAP13 ARHGEF17	3.83e-04	71	90	4	1.20.900.10
Domain	PDZ	MPP1 DLG2 SIPA1 SIPA1L2 AHNAK2	6.00e-04	141	90	5	PF00595
Domain	PDZ	MPP1 DLG2 SIPA1 SIPA1L2 AHNAK2	7.47e-04	148	90	5	SM00228
Domain	-	MPP1 DLG2 SIPA1 SIPA1L2 AHNAK2	7.94e-04	150	90	5	2.30.42.10
Domain	PDZ	MPP1 DLG2 SIPA1 SIPA1L2 AHNAK2	8.18e-04	151	90	5	PS50106
Domain	PDZ	MPP1 DLG2 SIPA1 SIPA1L2 AHNAK2	8.43e-04	152	90	5	IPR001478
Domain	Rap_GAP	SIPA1 SIPA1L2	1.01e-03	10	90	2	PF02145
Domain	Rap_GAP_dom	SIPA1 SIPA1L2	1.23e-03	11	90	2	IPR000331
Domain	RAPGAP	SIPA1 SIPA1L2	1.23e-03	11	90	2	PS50085
Domain	-	PPFIA2 NAB2 EPHA1 ANKS1A	1.72e-03	106	90	4	1.10.150.50
Domain	SAM/pointed	PPFIA2 NAB2 EPHA1 ANKS1A	2.47e-03	117	90	4	IPR013761
Domain	Guanylate_kinase_CS	MPP1 DLG2	2.64e-03	16	90	2	IPR020590
Domain	-	PLEKHG4B PLEKHG1 EVL MYO7A AKAP13 ARHGEF17 ANKS1A	2.81e-03	391	90	7	2.30.29.30
Domain	ZINC_FINGER_C2H2_2	KLF11 ZNF536 RBSN HIVEP2 KCMF1 ZNF76 KLF17 ZNF215 ZNF454 ZNF646	4.09e-03	775	90	10	PS50157
Domain	ZINC_FINGER_C2H2_1	KLF11 ZNF536 RBSN HIVEP2 KCMF1 ZNF76 KLF17 ZNF215 ZNF454 ZNF646	4.16e-03	777	90	10	PS00028
Domain	SAM_1	PPFIA2 EPHA1 ANKS1A	4.33e-03	68	90	3	PF00536
Domain	PH_dom-like	PLEKHG4B PLEKHG1 EVL MYO7A AKAP13 ARHGEF17 ANKS1A	4.50e-03	426	90	7	IPR011993
Domain	CRAL_TRIO	PRUNE2 SEC14L1	4.54e-03	21	90	2	PF00650
Domain	Znf_C2H2-like	KLF11 ZNF536 RBSN HIVEP2 KCMF1 ZNF76 KLF17 ZNF215 ZNF454 ZNF646	4.92e-03	796	90	10	IPR015880
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PITPNM2 PALD1 PLEKHG1 FLNA FOXK2 HIVEP2 PER2 MYO7A AKNA NSD1 AKAP13 PIGG ATG9A DOT1L HERC1 SIPA1L2 AHNAK2	3.81e-09	1105	91	17	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PLEKHG1 RBSN HIVEP2 SYDE2 APC AKAP13 USP54 SIPA1L2 SRRM2 ARHGEF17 AKAP1 LUZP1 AHNAK2 ANKS1A	5.35e-08	861	91	14	36931259
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	HIVEP2 PER2 APC AKAP13 USP54 SIPA1L2 PRPF39 SON	1.83e-07	232	91	8	25515538
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PRUNE2 ZNF536 PER2 SRRM2 ARHGEF17 ZNF646	3.35e-07	104	91	6	9205841
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	FLNA RBSN FOXK2 USP24 APC AKAP13 SRRM2 TERF2IP EPHA1 SON	8.26e-07	503	91	10	16964243
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PALD1 PLEKHG1 ZNF536 PER2 SIPA1L2 SRRM2 ARHGEF17 NFAT5 SON	1.27e-06	407	91	9	12693553
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	KLF11 HOXB5 ZNF536 RBSN FOXK2 HIVEP2 PER2 KLF17 PAX9 COPS6 NFAT5	2.52e-06	709	91	11	22988430
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	BDP1 FLNA NSD1 APC CHD1 SRRM2 SON	4.41e-06	250	91	7	33536335
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PITPNM2 EVL FLNA MYO7A PPFIA2 NCAN APC POR DLG2 USP54 NDUFA6 SIPA1 SIPA1L2 ARHGEF17 LUZP1	4.42e-06	1431	91	15	37142655
Pubmed	CD11b is required for the resolution of inflammation induced by Bordetella bronchiseptica respiratory infection.	C5 ITGAM	6.77e-06	2	91	2	16611225
Pubmed	Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death.	CASP3 C5	6.77e-06	2	91	2	17715065
Pubmed	Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis.	APC PTGER4	6.77e-06	2	91	2	26378024
Pubmed	Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice.	PSMB8 APC	6.77e-06	2	91	2	28881611
Pubmed	SON and SRRM2 are essential for nuclear speckle formation.	SRRM2 SON	6.77e-06	2	91	2	33095160
Pubmed	The COP9 signalosome-mediated deneddylation is stimulated by caspases during apoptosis.	CASP3 COPS6	6.77e-06	2	91	2	18060501
Pubmed	Period 2 mutation accelerates ApcMin/+ tumorigenesis.	PER2 APC	6.77e-06	2	91	2	19010825
Pubmed	Deafness due to degeneration of cochlear neurons in caspase-3-deficient mice.	MYO7A CASP3	6.77e-06	2	91	2	11374883
Pubmed	Granulocyte and monocyte CD11b expression during plasma separation is dependent on complement factor 5 (C5) - an ex vivo study with blood from a C5-deficient individual.	C5 ITGAM	6.77e-06	2	91	2	29575196
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NOL4 FLNA ZNF536 ZGRF1 USP24 APC AKAP1 LUZP1	1.45e-05	418	91	8	34709266
Pubmed	Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5.	AKAP13 NFAT5	2.03e-05	3	91	2	19211510
Pubmed	BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain.	PRUNE2 AKAP13	2.03e-05	3	91	2	18445682
Pubmed	Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.	APC PTGER4	2.03e-05	3	91	2	12841871
Pubmed	Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart.	AKAP13 AKAP1	2.03e-05	3	91	2	23045525
Pubmed	AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development.	PRKAB2 CASP3 APC	2.23e-05	21	91	3	19217427
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MPP1 PALD1 ZNF536 CASP3 APC AKAP13 CHD1 USP54 AKAP1 ANKS1A	2.25e-05	733	91	10	34672954
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PLEKHG4B PRUNE2 PITPNM2 BDP1 EVL FOXK2 HIVEP2 MCM8 PPFIA2 AKAP13 ANKRD24 NFAT5 TERF2IP ANKS1A	3.19e-05	1489	91	14	28611215
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	FLNA ZGRF1 NSD1 HERC1 SRRM2 ARHGEF17	3.60e-05	234	91	6	36243803
Pubmed	Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens.	MPP1 EVL PSMB8 AKAP13 ITGAM	3.83e-05	143	91	5	30397336
Pubmed	The role of Math1 in inner ear development: Uncoupling the establishment of the sensory primordium from hair cell fate determination.	MYO7A CASP3	4.05e-05	4	91	2	11973280
Pubmed	Intracellular complement C5a/C5aR1 stabilizes β-catenin to promote colorectal tumorigenesis.	APC C5	4.05e-05	4	91	2	35649359
Pubmed	Cloning and chromosomal mapping of four putative novel human G-protein-coupled receptor genes.	GPR20 GPR22	4.05e-05	4	91	2	9073069
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	PITPNM2 EVL FLNA RBSN PPFIA2 USP24 APC PKP1 POR DLG2 NDUFA6 SIPA1L2	4.19e-05	1139	91	12	36417873
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	PRUNE2 MYO7A LRRC53 PSMB8 MROH7 CHD1 SIPA1L2 LUZP1	4.88e-05	496	91	8	31343991
Pubmed	A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes.	AKAP13 NFAT5	6.74e-05	5	91	2	29298866
Pubmed	Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice.	PER2 APC	6.74e-05	5	91	2	19106159
Pubmed	The fate of desmosomal proteins in apoptotic cells.	CASP3 PKP1	6.74e-05	5	91	2	11500511
Pubmed	Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals.	CASP3 ITGAM	6.74e-05	5	91	2	17699657
Pubmed	Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor.	CASP3 ITGAM	6.74e-05	5	91	2	18685038
Pubmed	Embryonic lethality in mice lacking the nuclear factor of activated T cells 5 protein due to impaired cardiac development and function.	CASP3 NFAT5	6.74e-05	5	91	2	21765887
Pubmed	FilaminA and Formin2 regulate skeletal, muscular, and intestinal formation through mesenchymal progenitor proliferation.	FLNA CASP3	6.74e-05	5	91	2	29240780
Pubmed	Methionine sulfoxide reductase B3 deficiency causes hearing loss due to stereocilia degeneration and apoptotic cell death in cochlear hair cells.	MYO7A CASP3	6.74e-05	5	91	2	24191262
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	PITPNM2 PPFIA2 NCAN PKP1 DLG2 LUZP1	9.89e-05	281	91	6	28706196
Pubmed	Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice.	APC PTGER4	1.01e-04	6	91	2	11533709
Pubmed	Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.	C5 ITGAM	1.01e-04	6	91	2	16177324
Pubmed	ATG9A prevents TNF cytotoxicity by an unconventional lysosomal targeting pathway.	CASP3 ATG9A	1.01e-04	6	91	2	36520901
Pubmed	Complement inhibition and statins prevent fetal brain cortical abnormalities in a mouse model of preterm birth.	CASP3 C5	1.01e-04	6	91	2	24184716
Pubmed	POU4F3 pioneer activity enables ATOH1 to drive diverse mechanoreceptor differentiation through a feed-forward epigenetic mechanism.	MYO7A CASP3	1.01e-04	6	91	2	34266958
Pubmed	Fungal dissemination is limited by liver macrophage filtration of the blood.	C5 ITGAM	1.01e-04	6	91	2	31594939
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	MPP1 EVL FLNA PPFIA2 DLG2 ANKRD24 SIPA1 COPS6	1.13e-04	560	91	8	21653829
Pubmed	The Phox (PX) domain proteins and membrane traffic.	SNX20 KIF16B	1.41e-04	7	91	2	16782399
Pubmed	The role of sensory organs and the forebrain for the development of the craniofacial shape as revealed by Foxg1-cre-mediated microRNA loss.	MYO7A CASP3	1.41e-04	7	91	2	21225654
Pubmed	Modeling of a human circadian mutation yields insights into clock regulation by PER2.	PER2 APC	1.41e-04	7	91	2	17218255
Pubmed	Organ of Corti size is governed by Yap/Tead-mediated progenitor self-renewal.	MYO7A CASP3	1.41e-04	7	91	2	32482884
Pubmed	The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4.	C5 ITGAM	1.41e-04	7	91	2	16301658
Pubmed	Cross-regulation of Ngn1 and Math1 coordinates the production of neurons and sensory hair cells during inner ear development.	MYO7A CASP3	1.41e-04	7	91	2	18039969
Pubmed	Neurod1 regulates survival and formation of connections in mouse ear and brain.	MYO7A CASP3	1.41e-04	7	91	2	20512592
Pubmed	A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles.	C5 ITGAM PTGER4	1.48e-04	39	91	3	20962850
Pubmed	Biological insights from 108 schizophrenia-associated genetic loci.	PITPNM2 ZNF536 NCAN NAB2 PPP1R16B NDUFA6	1.49e-04	303	91	6	25056061
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	APC SRRM2 ARHGEF17 ANKS1A	1.53e-04	102	91	4	15778465
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	NOL4 ZNF536 MCM8 USP54 SIPA1 SIPA1L2 SRRM2 UNC80 LUZP1 SON ZNF646	1.60e-04	1116	91	11	31753913
Pubmed	C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens.	C5 ITGAM	1.88e-04	8	91	2	24474777
Pubmed	Neural crest-specific deletion of Ldb1 leads to cleft secondary palate with impaired palatal shelf elevation.	CASP3 PAX9	1.88e-04	8	91	2	24433583
Pubmed	Rack1 regulates cellular patterning and polarity in the mouse cochlea.	MYO7A FZD3	1.88e-04	8	91	2	36252648
Pubmed	CHD7 and SOX2 act in a common gene regulatory network during mammalian semicircular canal and cochlear development.	MYO7A CASP3	1.88e-04	8	91	2	38408234
Pubmed	In vivo genetic ablation of the periotic mesoderm affects cell proliferation survival and differentiation in the cochlea.	MYO7A CASP3	1.88e-04	8	91	2	17825816
Pubmed	The subunit CSN6 of the COP9 signalosome is cleaved during apoptosis.	CASP3 COPS6	1.88e-04	8	91	2	17337451
Pubmed	The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival.	MYO7A CASP3	1.88e-04	8	91	2	12441305
Pubmed	Frizzled3 is required for neurogenesis and target innervation during sympathetic nervous system development.	FZD3 CASP3	1.88e-04	8	91	2	21325504
Pubmed	Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling.	CASP3 APC	1.88e-04	8	91	2	29170395
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	EVL FLNA ARID4A USP24 SRRM2 AKAP1 TERF2IP SON ANKS1A	1.97e-04	774	91	9	15302935
Pubmed	Kit ligand has a critical role in mouse yolk sac and aorta-gonad-mesonephros hematopoiesis.	CASP3 ITGAM	2.41e-04	9	91	2	30166337
Pubmed	Function of bidirectional sensitivity in the otolith organs established by transcription factor Emx2.	MYO7A CASP3	2.41e-04	9	91	2	36280667
Pubmed	Casz1 is required for cardiomyocyte G1-to-S phase progression during mammalian cardiac development.	FLNA CASP3	2.41e-04	9	91	2	25953344
Pubmed	Emergence of hematopoietic stem and progenitor cells involves a Chd1-dependent increase in total nascent transcription.	CASP3 CHD1	2.41e-04	9	91	2	25831528
Pubmed	Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease.	CASP3 C5	2.41e-04	9	91	2	15917267
Pubmed	Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.	APC PTGER4	2.41e-04	9	91	2	11782353
Pubmed	Urothelial Defects from Targeted Inactivation of Exocyst Sec10 in Mice Cause Ureteropelvic Junction Obstructions.	CASP3 UPK3A	2.41e-04	9	91	2	26046524
Pubmed	Interaction of TAGLN and USP1 promotes ZEB1 ubiquitination degradation in UV-induced skin photoaging.	USP24 USP54	2.41e-04	9	91	2	37149635
Pubmed	Msx1 haploinsufficiency modifies the Pax9-deficient cardiovascular phenotype.	CASP3 PAX9	2.41e-04	9	91	2	34615475
Pubmed	A core cochlear phenotype in USH1 mouse mutants implicates fibrous links of the hair bundle in its cohesion, orientation and differential growth.	MYO7A FZD3	2.41e-04	9	91	2	18339676
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	EVL RBSN PPFIA2 SIPA1L2 LUZP1	2.77e-04	218	91	5	33378226
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	MPP1 FLNA USP24 ITGAM SRRM2 SON	2.95e-04	344	91	6	30333137
Pubmed	Celsr3 is required in motor neurons to steer their axons in the hindlimb.	FZD3 CASP3	3.01e-04	10	91	2	25108913
Pubmed	Conditional deletion of Atoh1 reveals distinct critical periods for survival and function of hair cells in the organ of Corti.	MYO7A CASP3	3.01e-04	10	91	2	23761906
Pubmed	Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS.	CASP3 APC	3.01e-04	10	91	2	19515974
Pubmed	Tissue-resident ductal macrophages survey the mammary epithelium and facilitate tissue remodelling.	CASP3 ITGAM	3.01e-04	10	91	2	32341550
Pubmed	Microglia proliferation is controlled by P2X7 receptors in a Pannexin-1-independent manner during early embryonic spinal cord invasion.	CASP3 ITGAM	3.01e-04	10	91	2	22915101
Pubmed	Interaction network of human early embryonic transcription factors.	NOL4 ZNF536 FOXK2 HIVEP2 ARID4A NAB2	3.28e-04	351	91	6	38297188
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	PALD1 ANOS1 ZGRF1 NCAN USP24 NSD1 CHD1 ANKRD24 USP54 SIPA1L2 EPHA1	3.32e-04	1215	91	11	15146197
Pubmed	FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability.	FNDC3B HERC1 SRRM2 SON	3.65e-04	128	91	4	28027390
Pubmed	Embryonic macrophages and microglia ablation alter the development of dorsal root ganglion sensory neurons in mouse embryos.	CASP3 ITGAM	3.67e-04	11	91	2	30252950
Pubmed	Metabolic-stress-induced rearrangement of the 14-3-3ζ interactome promotes autophagy via a ULK1- and AMPK-regulated 14-3-3ζ interaction with phosphorylated Atg9.	AKAP13 ATG9A	3.67e-04	11	91	2	25266655
Pubmed	Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence.	PLEKHG1 RBSN	3.67e-04	11	91	2	22488850
Pubmed	An Atoh1-S193A Phospho-Mutant Allele Causes Hearing Deficits and Motor Impairment.	MYO7A CASP3	3.67e-04	11	91	2	28729444
Pubmed	Control of oligodendrocyte generation and proliferation by Shp2 protein tyrosine phosphatase.	CASP3 APC	3.67e-04	11	91	2	20648636
Pubmed	Developmental basis for filamin-A-associated myxomatous mitral valve disease.	FLNA CASP3	3.67e-04	11	91	2	22843703
Pubmed	The adenomatous polyposis coli protein is an essential regulator of radial glial polarity and construction of the cerebral cortex.	CASP3 APC	3.67e-04	11	91	2	19146812
Pubmed	Rab11a Is Essential for the Development and Integrity of the Stereocilia and Kinocilia in the Mammalian Organ of Corti.	MYO7A FZD3	3.67e-04	11	91	2	37225424
Pubmed	Defects in the Alternative Splicing-Dependent Regulation of REST Cause Deafness.	MYO7A CASP3	3.67e-04	11	91	2	29961578
Pubmed	Pax9 is required for cardiovascular development and interacts with Tbx1 in the pharyngeal endoderm to control 4th pharyngeal arch artery morphogenesis.	CASP3 PAX9	3.67e-04	11	91	2	31444215
Interaction	YWHAH interactions	PLEKHG1 RBSN HIVEP2 SYDE2 APC AKAP13 ATG9A USP54 HERC1 SIPA1 SIPA1L2 SRRM2 ARHGEF17 AKAP1 LUZP1 AHNAK2 ANKS1A	5.59e-06	1102	89	17	int:YWHAH
Interaction	YWHAG interactions	PLEKHG1 FLNA HIVEP2 SYDE2 USP24 CASP3 APC AKAP13 ATG9A USP54 SIPA1 SIPA1L2 SRRM2 ARHGEF17 LUZP1 SON AHNAK2 ANKS1A	7.19e-06	1248	89	18	int:YWHAG
Interaction	FBXW11 interactions	FLNA HIVEP2 PER2 CASP3 APC AKAP13 CHD1 USP54 SIPA1L2 PRPF39 SON	7.45e-06	473	89	11	int:FBXW11
Interaction	RCOR1 interactions	NOL4 FLNA ZNF536 FOXK2 ARID4A ZGRF1 USP24 APC AKAP1 TERF2IP LUZP1	1.12e-05	494	89	11	int:RCOR1
Interaction	TOP3B interactions	PITPNM2 PALD1 PLEKHG1 FLNA ANOS1 FOXK2 HIVEP2 PER2 MYO7A KCMF1 AKNA NSD1 AKAP13 PIGG ATG9A DOT1L HERC1 SIPA1L2 AHNAK2	1.82e-05	1470	89	19	int:TOP3B
Interaction	GSN interactions	PLEKHG1 FLNA PER2 SYDE2 CASP3 DOT1L ARHGEF17	4.29e-05	212	89	7	int:GSN
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MYO7A AKAP13 AKAP1	2.05e-04	29	72	3	396
GeneFamily	PDZ domain containing	MPP1 DLG2 SIPA1 SIPA1L2 AHNAK2	3.50e-04	152	72	5	1220
GeneFamily	Zinc fingers C2H2-type\|Kruppel like factors	KLF11 KLF17	2.30e-03	18	72	2	624
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG1 AKAP13 ARHGEF17	2.32e-03	66	72	3	722
GeneFamily	CD molecules\|Mucins	MUC16 MUC22	3.13e-03	21	72	2	648
GeneFamily	Fibronectin type III domain containing	FNDC3B ANOS1 CNTN3 EPHA1	3.81e-03	160	72	4	555
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	MPP1 DLG2	4.78e-03	26	72	2	904
GeneFamily	Sterile alpha motif domain containing	PPFIA2 EPHA1 ANKS1A	5.22e-03	88	72	3	760
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	PPP1R16B APC DLG2 AKAP1	5.89e-03	181	72	4	694
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	KLF11 ZNF536 HIVEP2 ZNF76 KLF17 ZNF215 ZNF454 ZNF646	7.58e-03	718	72	8	28
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	NSD1 DOT1L	8.08e-03	34	72	2	487
GeneFamily	Complement system\|Sushi domain containing	C5 ITGAM	9.03e-03	36	72	2	492
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	BDP1 EVL FLNA HIVEP2 ARID4A MYO7A KCMF1 USP24 PSMB8 PPP1R16B AKNA NSD1 AKAP13 CHD1 HERC1 SIPA1 NFAT5 PTGER4 TERF2IP LUZP1 SON	1.60e-08	1492	88	21	M40023
Coexpression	GSE13522_WT_VS_IFNG_KO_SKIN_UP	NOL4 FZD3 CLEC1A CNTN3 KLF17 UNC80 EPHA1	4.28e-07	138	88	7	M2913
Coexpression	GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN	FLNA ZNF536 ARID4A SNX20 PRKAB2 C5 HERC1	4.94e-06	199	88	7	M7998
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL	PLEKHG4B PRUNE2 ANOS1 FZD3 KCMF1 PRKAB2 SIPA1L2 AKAP1 AHNAK2 ANKS1A	2.85e-05	589	88	10	M45662
Coexpression	GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP	KLF11 RBSN FOXK2 USP24 ATG9A ANKS1A	4.44e-05	190	88	6	M3289
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	KIF16B APC PKP1	5.38e-05	22	88	3	M14523
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	KIF16B APC PKP1	5.38e-05	22	88	3	MM676
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN	PER2 MYO7A POR ITGAM SEC14L1 ANKS1A	5.90e-05	200	88	6	M5204
Coexpression	GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN	EVL HIVEP2 SNX20 ZNF76 AKAP13 C5	5.90e-05	200	88	6	M8618
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	RBSN HIVEP2 FZD3 NSD1 POR USP54 HERC1 SRRM2 AKAP1 PTGER4 ANKS1A	8.15e-05	807	88	11	M16651
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PITPNM2 PALD1 PLEKHG1 CLEC1A SIPA1L2 LUZP1 SEC14L1	8.90e-08	180	91	7	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MPP1 PITPNM2 PLEKHG1 PSMB8 PPP1R16B CLEC1A SIPA1	1.20e-07	188	91	7	b294d6658e79328bd6fa33223e8c70117ba9789b
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PITPNM2 PALD1 PLEKHG1 CLEC1A SIPA1L2 LUZP1 SEC14L1	1.33e-07	191	91	7	1de0bdfd13bd930691564c2673f2e66393bc0255
ToppCell	Sigmoid-Macrophage-Macrophage\|Macrophage / Region, Cell class and subclass	PALD1 FNDC3B EVL AKNA PTGER4 SEC14L1	1.27e-06	168	91	6	bb16e135b6ae0d66615420b61edd6f62f2a3233c
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PITPNM2 PALD1 PLEKHG1 PPP1R16B SIPA1L2 SEC14L1	2.67e-06	191	91	6	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature2_(1)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MPP1 PITPNM2 PSMB8 PPP1R16B CLEC1A SIPA1	2.75e-06	192	91	6	f68e6cbde87678122da1b5c0061904cfb7d04bf5
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	PITPNM2 PALD1 PLEKHG1 CLEC1A SIPA1L2 SEC14L1	2.75e-06	192	91	6	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PITPNM2 PLEKHG1 PPP1R16B CLEC1A SIPA1L2 SEC14L1	2.84e-06	193	91	6	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BDP1 PER2 NSD1 CHD1 LUZP1 SON	2.92e-06	194	91	6	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PALD1 PLEKHG1 PPP1R16B CLEC1A SIPA1L2 SEC14L1	3.01e-06	195	91	6	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PITPNM2 PALD1 PLEKHG1 CLEC1A SIPA1L2 SEC14L1	3.10e-06	196	91	6	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SIPA1L2 SEC14L1	3.10e-06	196	91	6	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PALD1 PLEKHG1 PPP1R16B CLEC1A SIPA1L2 SEC14L1	3.10e-06	196	91	6	b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	PITPNM2 PALD1 PLEKHG1 CLEC1A SIPA1L2 SEC14L1	3.10e-06	196	91	6	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANOS1 PKP1 MUC16 CNTN3 PAX9 SIPA1L2	3.19e-06	197	91	6	107cb153ea7fc74bbd244dbb9d0499c0a8506724
ToppCell	Bronchial_Biopsy\|World / Tissue, Lineage and Cell class of Lung Cells from 10X	ANOS1 PER2 PKP1 PAX9 NFAT5 AHNAK2	3.29e-06	198	91	6	f5b7013045b61fc56894f80092f799770dde1c8f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MPP1 PALD1 NAB2 AKAP13 DOT1L LUZP1	3.39e-06	199	91	6	b0a906586e58009f5ed9272fc29ba28e49c85ee6
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	NOL4 HIVEP2 GPR22 PPFIA2 DLG2 TERF2IP	3.39e-06	199	91	6	1029f3458b7fda464aa0e7ef06e081e2618c1388
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal-PNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	NOL4 HIVEP2 GPR22 PPFIA2 DLG2 TERF2IP	3.39e-06	199	91	6	8a04398653a1794921d73a6a950c1fb6fdf68c85
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	PRUNE2 SYDE2 PRKAB2 PSMB8 PIGG ANKS1A	3.48e-06	200	91	6	6b7314c425f6b40f1301dd39cc02b0436e96a2ec
ToppCell	Control-Endothelial_cells-Inflamed_endothelial_cells\|Control / group, cell type (main and fine annotations)	PALD1 PLEKHG1 CLEC1A SIPA1L2 SEC14L1	1.94e-05	160	91	5	958256e3d3836160763b82bb48f794087918d935
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PER2 MCM8 ZGRF1 ATG9A USP54	2.60e-05	170	91	5	b1a16600754e0c12f7d39c9221f1b03135833f16
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PKP1 SEC14L1 ANKS1A	2.82e-05	173	91	5	f193c63cc536d891c9d23043765e320252bb6e65
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PKP1 MUC16 USP54 PAX9 AHNAK2	3.07e-05	176	91	5	8d9d0fb46c418b2067be58aec822e8c2b1561461
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA PPP1R16B AKNA ITGAM UNC80	3.07e-05	176	91	5	6b06da40eb97ea2db09f3a769494738b3e5fe3fa
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSMB8 NSD1 CHD1 SRRM2 LUZP1	3.24e-05	178	91	5	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	3.32e-05	179	91	5	8f9e538c822940785130297712b75131812a4603
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PRUNE2 PITPNM2 HIVEP2 PPP1R16B DLG2	3.32e-05	179	91	5	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PITPNM2 PLEKHG1 PPP1R16B SIPA1L2 SEC14L1	3.41e-05	180	91	5	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	PALD1 PLEKHG1 CLEC1A SIPA1L2 SEC14L1	3.41e-05	180	91	5	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	PITPNM2 PALD1 PLEKHG1 CLEC1A SEC14L1	3.50e-05	181	91	5	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PITPNM2 PALD1 PLEKHG1 CLEC1A SEC14L1	3.60e-05	182	91	5	a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	ANOS1 PKP1 CNTN3 PAX9 C2orf78	3.69e-05	183	91	5	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SIPA1L2	3.79e-05	184	91	5	688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 HIVEP2 CLEC1A SIPA1L2 LUZP1	3.79e-05	184	91	5	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	P28-Endothelial\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PSMB8 PPP1R16B CLEC1A SIPA1 LUZP1	3.79e-05	184	91	5	b056411f499866097f4322999cfd1e57a3927b78
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA GPR20 MYO7A DOT1L ARHGEF17	3.89e-05	185	91	5	38486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PITPNM2 PLEKHG1 CLEC1A SIPA1L2 SEC14L1	3.89e-05	185	91	5	673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA GPR20 MYO7A DOT1L ARHGEF17	3.89e-05	185	91	5	3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCell	P28-Endothelial-capillary_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PSMB8 PPP1R16B CLEC1A SIPA1 LUZP1	3.99e-05	186	91	5	26a625ca0300055d6af3472aa0bfba59b73db292
ToppCell	PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating2_(14)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MPP1 PITPNM2 PPP1R16B CLEC1A SIPA1	3.99e-05	186	91	5	2cbf1aaff87cd9fba01f814a119fe86e5af82290
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ARID4A KIF16B APC NFAT5 LUZP1	3.99e-05	186	91	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PLEKHG1 CLEC1A SIPA1L2 LUZP1	4.09e-05	187	91	5	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	PALD1 PLEKHG1 CLEC1A SEC14L1 ANKS1A	4.09e-05	187	91	5	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD1 NDUFA6 SRRM2 LUZP1 SON	4.20e-05	188	91	5	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 PITPNM2 ZNF536 GPR20 AKAP1	4.20e-05	188	91	5	f54b063025d80de631382bf5326bc40aab7f7d00
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 FLNA ZNF536 ANOS1 AHNAK2	4.31e-05	189	91	5	da9ecc0d7b81c1901f30f97bb44112dc85444a66
ToppCell	ASK452-Immune-T_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	PPFIA2 MUC16 HERC1 PTGER4 TERF2IP	4.31e-05	189	91	5	f5dc500f77f04a110dd4a65cf4c03068a495dbdb
ToppCell	Control-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PLEKHG1 CLEC1A SIPA1L2 SEC14L1	4.31e-05	189	91	5	5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NOL4 HOXB5 PPFIA2 LRRC53 UNC80	4.41e-05	190	91	5	40d8b3403f4e38436b961cd3a2e69826cbae3042
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NOL4 HOXB5 PPFIA2 LRRC53 UNC80	4.41e-05	190	91	5	f6cbf6d292f488ada5f7581e1dceba6198b933d1
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	PITPNM2 PLEKHG1 CLEC1A PKP1 SEC14L1	4.41e-05	190	91	5	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLEKHG4B PRUNE2 FLNA SYDE2 AHNAK2	4.41e-05	190	91	5	e102622f05c7f3e1bd8b224ea159d57033793ee0
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NOL4 HOXB5 PPFIA2 LRRC53 UNC80	4.41e-05	190	91	5	a9a705455019e28d655636de73b07540798f82e6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	4.53e-05	191	91	5	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating1_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MPP1 PLEKHG1 PSMB8 PPP1R16B CLEC1A	4.53e-05	191	91	5	edfd5eeff69b5de19c5df3d899e42acd7e015913
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 FLNA ANOS1 SYDE2 AHNAK2	4.53e-05	191	91	5	de2cd94ee88a7754f86d39469e38374d668210c7
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PITPNM2 PALD1 PLEKHG1 CLEC1A SEC14L1	4.53e-05	191	91	5	f229abf69a1217194f74b0502486907e07dba989
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PLEKHG1 PPP1R16B CLEC1A SIPA1L2	4.64e-05	192	91	5	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating2_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MPP1 PITPNM2 PSMB8 PPP1R16B CLEC1A	4.64e-05	192	91	5	ac3d87aa301d30515c369bd7fc16f33b82173a85
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PLEKHG1 PPP1R16B CLEC1A SIPA1L2	4.64e-05	192	91	5	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	4.64e-05	192	91	5	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PITPNM2 PALD1 PLEKHG1 CLEC1A SEC14L1	4.76e-05	193	91	5	f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PLEKHG1 PPP1R16B CLEC1A SIPA1L2	4.76e-05	193	91	5	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature1_(0)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MPP1 PITPNM2 PSMB8 PPP1R16B CLEC1A	4.76e-05	193	91	5	2661ad9107ed9231e4afea4442a79051139a31df
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PLEKHG1 CLEC1A SIPA1L2 SEC14L1	4.76e-05	193	91	5	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PLEKHG1 CLEC1A SIPA1L2 SEC14L1	4.76e-05	193	91	5	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)\|Adult / Lineage, Cell type, age group and donor	PITPNM2 PALD1 PLEKHG1 CLEC1A PKP1	4.76e-05	193	91	5	39c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCell	PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating3_(3)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MPP1 PITPNM2 PSMB8 PPP1R16B CLEC1A	4.76e-05	193	91	5	f7e4a390921780587b9bd084e495e646fa1ec74f
ToppCell	PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating3_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PITPNM2 PSMB8 PPP1R16B CLEC1A SIPA1	4.76e-05	193	91	5	72128ece598070f8e752a0691e024e26ab364989
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	PITPNM2 PLEKHG1 CLEC1A PKP1 SEC14L1	4.76e-05	193	91	5	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PLEKHG1 CLEC1A SIPA1L2 LUZP1	4.76e-05	193	91	5	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	4.76e-05	193	91	5	52e918884877b6659cdca0496390e440f73694a9
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MPP1 PLEKHG4B EVL PSMB8 TERF2IP	4.87e-05	194	91	5	f64da5f62e29253d60b9546edf734ba5c17daae1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	4.87e-05	194	91	5	f76808666fb875fc787751cbfd924d9be20a8192
ToppCell	PCW_05-06-Endothelial\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MPP1 PITPNM2 PSMB8 PPP1R16B CLEC1A	4.87e-05	194	91	5	00291c62795a55a7e63b1db10c139d6a3298e55e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	4.87e-05	194	91	5	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PLEKHG1 PPP1R16B CLEC1A SIPA1L2	4.87e-05	194	91	5	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	PCW_05-06-Endothelial-Endothelial_immature\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MPP1 PITPNM2 PSMB8 PPP1R16B CLEC1A	4.87e-05	194	91	5	9bd25ea57f2da27bd200d1a8bf797fec77d172c7
ToppCell	PCW_05-06-Endothelial-Endothelial_cycling\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MPP1 PITPNM2 PSMB8 PPP1R16B CLEC1A	4.87e-05	194	91	5	eb279e0d922de921343f0ae032a809f837d915b3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	4.87e-05	194	91	5	f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	4.87e-05	194	91	5	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|Liver / Manually curated celltypes from each tissue	PER2 PPP1R16B AKNA SRRM2 PTGER4	4.99e-05	195	91	5	972b09697b7b66fb8a27dfc0c0b05a844121f055
ToppCell	10x5'-Liver-Lymphocytic_T_CD4/8-lo\|Liver / Manually curated celltypes from each tissue	PER2 PPP1R16B AKNA SRRM2 PTGER4	4.99e-05	195	91	5	c29c4ae95a756e3ced0f0747bbfe343590e5b8ab
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD1 HERC1 SRRM2 UNC80 SON	4.99e-05	195	91	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	PITPNM2 PLEKHG1 PPP1R16B CLEC1A SEC14L1	4.99e-05	195	91	5	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	PCW_07-8.5-Endothelial-Endothelial_cycling\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MPP1 PITPNM2 PSMB8 PPP1R16B CLEC1A	4.99e-05	195	91	5	804b7c44aaaf8ba77e36f377955df261e92f5ff9
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	PLEKHG1 PPP1R16B HERC1 SEC14L1 ANKS1A	5.12e-05	196	91	5	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	5.12e-05	196	91	5	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 EVL USP24 PPP1R16B PRPF39	5.12e-05	196	91	5	0175b097ad1338a07afebe3b5c7fd0bb0bb950f7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	5.12e-05	196	91	5	b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCell	Fetal_29-31_weeks-Endothelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	5.12e-05	196	91	5	3981f6c7487598f4f7ce4650ac0ac5bd41481d66
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	5.12e-05	196	91	5	145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	5.12e-05	196	91	5	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	5.12e-05	196	91	5	e224338490691d92c1f70b57112fabdcc92b06a9
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	5.12e-05	196	91	5	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	5.12e-05	196	91	5	d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PLEKHG1 PPP1R16B CLEC1A SEC14L1	5.24e-05	197	91	5	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 FLNA ZNF536 GPR20 PPFIA2	5.24e-05	197	91	5	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 FLNA ANOS1 GPR20 AHNAK2	5.24e-05	197	91	5	4797f414330316e2ac2cf7cd2570d991877d7a38
Disease	neutropenia (implicated_via_orthology)	C5 ITGAM	1.83e-04	7	88	2	DOID:1227 (implicated_via_orthology)
Disease	puberty onset measurement	FNDC3B ZNF536 AKAP1 NFAT5	5.44e-04	125	88	4	EFO_0005677
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	PITPNM2 USP24 SIPA1 ITGAM NFAT5	5.44e-04	222	88	5	EFO_0008317, EFO_0020943
Disease	systemic lupus erythematosus, COVID-19	PSMB8 CLEC1A ITGAM	7.02e-04	58	88	3	MONDO_0007915, MONDO_0100096
Disease	attention deficit hyperactivity disorder, schizophrenia	ZNF536 NAB2 PPP1R16B	9.36e-04	64	88	3	EFO_0003888, MONDO_0005090
Disease	Tourette syndrome, schizophrenia	PITPNM2 ZNF536	1.30e-03	18	88	2	EFO_0004895, MONDO_0005090
Disease	cardiovascular disease	PLEKHG1 HOXB5 HIVEP2 DLG2 SIPA1L2 NFAT5	2.48e-03	457	88	6	EFO_0000319
Disease	pallidum volume	DLG2 HAL	2.52e-03	25	88	2	EFO_0006933
Disease	level of Sterol ester (27:1/16:0) in blood serum	NCAN USP24	2.73e-03	26	88	2	OBA_2045191
Disease	systemic scleroderma, systemic lupus erythematosus	ITGAM ANKS1A	2.73e-03	26	88	2	EFO_0000717, MONDO_0007915
Disease	coronary artery disease	PLEKHG1 FNDC3B HIVEP2 ARID4A AKAP13 C5 SIPA1 MUC22 NFAT5 ANKS1A	2.93e-03	1194	88	10	EFO_0001645
Disease	eye measurement	AKAP13 HERC1	2.94e-03	27	88	2	EFO_0004731

Protein segments in the cluster

Peptide	Gene	Start	Entry
TSVSISMGHAESLSG	EPHA1	436	P21709
TSTSRQTDTHLMQSG	BDP1	1326	A6H8Y1
EADHSGGSDRNSMDS	AKAP1	566	Q92667
DREVSHAGASMSSAS	ARID4A	1221	P29374
DHVARMTATGSGENS	COPS6	201	Q7L5N1
MTATGSGENSTVAEH	COPS6	206	Q7L5N1
HSSTTMLSGVTGQSH	C2orf78	101	A6NCI8
IATGSSMRSDGTDNA	ADAM18	581	Q9Y3Q7
SSGDVVSMHRSSKGS	GPR20	321	Q99678
GLSTSSTAAELQHGM	AKAP13	846	Q12802
MGNTTSDRVSGERHG	PRKAB2	1	O43741
HSLDSMASGRSSDQD	ANKS1A	371	Q92625
SSAATRLTNSHAMGS	DOT1L	1511	Q8TEK3
GSRATGMESTGVSAT	ANKRD24	676	Q8TF21
HKSTGMTSRSGTDVD	CASP3	56	P42574
MNGHSDEESVRNSSG	CHD1	1	O14646
TAATGMNDVSSRSHA	KIF16B	211	Q96L93
SSKETMNVASSGHSR	MROH7	271	Q68CQ1
MNVASSGHSRSDLSV	MROH7	276	Q68CQ1
AMGSEQDSTPESRHG	NSD1	206	Q96L73
NSVHGSRRGSISSMS	RBSN	221	Q9H1K0
VDEHGTRLSGNMFST	PSMB8	186	P28062
LQGSGTMDSRHSVSI	PALD1	21	Q9ULE6
ATSAMDEGLTSGHSD	ARHGEF17	771	Q96PE2
STMGDRGTSNHSEMT	OR9K2	21	Q8NGE7
RTTGSEASSGMTHEN	ANOS1	471	P23352
SMAVTNVGTTSSGHE	MUC16	10101	Q8WXI7
MQAAREGSHSVTASA	PAX9	326	P55771
MGDSHVDTSSTVSEA	POR	1	P16435
FERSQHGSGMSNRST	MCM8	761	Q9UJA3
STMGASSTTSAHGVR	MUC22	1601	E2RYF6
SETAGTRKGSMSNGH	NAB2	131	Q15742
SQGSVDVSMGHSSFI	FOXK2	61	Q01167
ATDQGTTESTEHMGQ	LRRC53	896	A6NM62
STSASEGGGLMTRSE	HERC1	1476	Q15751
DVDMSSGSSGHETNE	PER2	31	O15055
SQRTSSAMSGHSRSF	PTGER4	366	P35408
QGSSHDESSMSGLAA	EVL	211	Q9UI08
MAGSGVRQATSTAST	NDUFA6	1	P56556
CSRHSSSSTMLDGTG	PITPNM2	696	Q9BZ72
RETSVASMSQTSGGE	NFAT5	41	O94916
HTEDTTSSSTQMIDG	PRPF39	621	Q86UA1
GMDLSVNRSSASSSH	HOXB5	51	P09067
HLGSSMARTGESSSE	PPP1R16B	501	Q96T49
MGTSSTDSQQAGHRR	CEMP1	1	Q6PRD7
SLSTSAATEDHVSMG	HAL	521	P42357
MSSSHSRAGQSAAGA	FLNA	1	P21333
DLGDTSITVGNTTMH	FNDC3B	906	Q53EP0
TMTGSGVDARTASSG	ATG9A	671	Q7Z3C6
SREESSSGSSHAVMD	C5	1411	P01031
ASHQSSMTSLEGSGI	AKNA	881	Q7Z591
AAKASHMGVSTDSGT	LUZP1	431	Q86V48
HGTSMNRVIEEDGTS	FZD3	651	Q9NPG1
SDSGDVTTTVHMDAA	KLF11	76	O14901
ARRSNMHFTSSSTGG	KCMF1	166	Q9P0J7
LNMSSSSGSSGVHTS	KLF17	36	Q5JT82
NHSMSSGSGSLRTNQ	DLG2	521	Q15700
SEGESGGSMHTALSD	MPP1	6	Q00013
HEATDMSQSSGGRNV	GPR22	266	Q99680
RGSMTSLESSHSGFS	SEC14L1	681	Q92503
SMDARGSTSAISNVH	CNTN3	996	Q9P232
ASSEGSTESEHLEGM	PPFIA2	231	O75334
SSQSSTLSHSNRGSM	PKP1	56	Q13835
SEHAGDIQTTRSNGM	SYDE2	426	Q5VT97
ATTTSSAGDHNGMLS	SRRM2	2481	Q9UQ35
SQRNSGETTETSDGM	PRUNE2	1436	Q8WUY3
SDMGAGTAASSHTEV	NCAN	456	O14594
GSMGDLSEISSHSSG	SIPA1L2	1331	Q9P2F8
RSQGMGSHSEASSGT	SIPA1	131	Q96FS4
EGTQTGSSSSFEHEM	ITGAM	336	P11215
IASGGTHSREMGDSN	NOL4	276	O94818
THSREMGDSNSDGKT	NOL4	281	O94818
HLSTAGMTGDELSTS	AHNAK2	5281	Q8IVF2
NGQGSTTRMDHETAS	APC	276	P25054
GDTTMSLHSQGSATT	CLEC1A	16	Q8NC01
HSGLSSNSSMTTREL	SNX20	46	Q7Z614
GTTTANHTMSSGVNT	UNC80	2436	Q8N2C7
ESQMRGSTAVSSSDH	PLEKHG4B	1166	Q96PX9
DQVSMLSGHSSSSLG	STYXL2	766	Q5VZP5
RQAHSSSGMTEGSEE	ZNF646	901	O15015
DMGSSDGETTHDSQI	UPK3A	236	O75631
SGDHSGQATGMSSEV	ZNF536	866	O15090
TVSGMARQDSSSEVG	USP24	1916	Q9UPU5
SATSGVMVRGHSSQL	ZGRF1	946	Q86YA3
SISGEESSHGVIMTR	ZNF215	241	Q9UL58
GSTMSSSLHSDQSQG	ZNF454	156	Q8N9F8
GQMESTETSSSGHRI	PLEKHG1	591	Q9ULL1
MSETGSHGASSTEEV	PIGG	271	Q5H8A4
DMEHSSGESSFESTG	HIVEP2	946	P31629
SETAETFDSMRASGH	SON	1306	P18583
SGTHTVTMVSADGTQ	ZNF76	481	P36508
HSSTLFVRDDGSSMS	TERF2IP	16	Q9NYB0
MSQSSRDTGHLTDSE	USP54	431	Q70EL1
SLGSGSDHVMDAISQ	MYO7A	1311	Q13402